Search Results - "RYDEN, Anna"

Response Burden and Questionnaire Length: Is Shorter Better? A Review and Meta-analysis by Rolstad, Sindre, PhD, Adler, John, PhLic, Rydén, Anna, PhD

“…Abstract Background Response burden is often defined as the effort required by the patient to answer a questionnaire. A factor that has been proposed to affect…”
Get full text

Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions by Walding, Andrew, Skaltsa, Konstantina, Casamayor, Montserrat, Rydén, Anna

“…Purpose The clinical relevance of different time-to-deterioration ( TTD) definitions for patient-reported outcomes were explored. Methods TTD definitions…”
Get full text

Patient-Reported Symptoms and Impact of Treatment With Osimertinib Versus Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The AURA3 Trial by Lee, Chee Khoon, Novello, Silvia, Rydén, Anna, Mann, Helen, Mok, Tony

“…Purpose Capturing patient-reported outcome data is important for evaluating the overall clinical benefits of new cancer therapeutics. We assessed self-reported…”
Get full text

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study by Hui, Rina, Özgüroğlu, Mustafa, Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Yokoi, Takashi, Chiappori, Alberto, Lee, Ki Hyeong, de Wit, Maike, Cho, Byoung Chul, Gray, Jhanelle E, Rydén, Anna, Viviers, Louis, Poole, Lynne, Zhang, Yiduo, Dennis, Phillip A, Antonia, Scott J

“…In the ongoing, phase 3 PACIFIC trial, durvalumab improved the primary endpoints of progression-free survival and overall survival compared with that for…”
Get full text

Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - a longitudinal study by Johansson, Mia, Rydén, Anna, Finizia, Caterina

“…Using a longitudinal design, aim of this study was to investigate the relation between mental adjustment to cancer and anxiety, depression, health-related…”
Get full text

Willingness to report treatment-related symptoms of immunotherapy among patients with non-small cell lung cancer by Martin, Mona L., Chung, Helena, Rydén, Anna

“…Purpose Immunotherapy is an evolving therapeutic approach for non-small cell lung cancer (NSCLC). This study explored factors involved in patients’ perceptions…”
Get full text

Patient-reported symptoms possibly related to treatment with osimertinib or chemotherapy for advanced non-small cell lung cancer by Sebastian, Martin, Rydén, Anna, Walding, Andrew, Papadimitrakopoulou, Vassiliki

“…•AURA3 was a phase III randomized controlled trial in patients with advanced NSCLC.•PRO-CTCAE — data provided insights into patient experiences of treatment…”
Get full text

How patients being treated for non-small cell lung cancer value treatment benefit despite side effects by Martin, Mona L., Correll, Julia, Walding, Andrew, Rydén, Anna

“…Purpose To describe symptoms and side effects experienced by patients with advanced non-small cell lung cancer (NSCLC), assess how patients allocate sensations…”
Get full text

Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer by Leighl, Natasha B., Karaseva, Nina, Nakagawa, Kazuhiko, Cho, Byoung-Chul, Gray, Jhanelle E., Hovey, Tina, Walding, Andrew, Rydén, Anna, Novello, Silvia

“…In the FLAURA trial, osimertinib demonstrated superior progression-free survival and a favorable toxicity profile to erlotinib or gefitinib as initial therapy…”
Get full text

Talking About Breast Cancer: Which Symptoms and Treatment Side Effects are Important to Patients with Advanced Disease? by Niklasson, Anna, Paty, Jean, Rydén, Anna

“…Background Patients’ experience of symptoms and associated treatment is an increasingly important consideration in both regulatory and health technology…”
Get full text

Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in Patients with Head and Neck Cancer and Neurologic Swallowing Disturbances by Carlsson, Sigrid, Rydén, Anna, Rudberg, Ingrid, Bove, Mogens, Bergquist, Henrik, Finizia, Caterina

“…The aim of this study was to validate the Swedish version of the dysphagia-specific quality-of-life questionnaire, the M. D. Anderson Dysphagia Inventory…”
Get full text

Altered immune profile from pre-diabetes to manifestation of type 1 diabetes by Rydén, Anna, Faresjö, Maria

“…Abstract Background While the mechanisms leading to β-cell destruction and clinical onset of T1D are still unclear, the composition of the immune profile is…”
Get full text

Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms by Vakil, Nimish B, Halling, Katarina, Becher, Anja, Rydén, Anna

“…Gastroesophageal reflux disease (GERD) symptoms are best assessed using patient-reported outcome (PRO) instruments. Guidance on developing well-defined and…”
Get full text

Clinical hypnosis can reduce lower urinary tract symptoms in individuals with chronic pain by McKernan, Lindsey C., Connors, Erin L., Ryden, Anna M., Finn, Michael T. M., Kim, Ahra, Vandekar, Simon N., Dmochowski, Roger R., Reynolds, W. Stuart

“…Study Purpose Lower urinary tract symptoms (LUTS) can occur in chronic pain populations at high rates and drastically affect quality of life. Hypnosis is a…”
Get full text

Development and validation of the Gothenburg Trismus Questionnaire (GTQ) by Johnson, Joakim, Carlsson, Sigrid, Johansson, Mia, Pauli, Nina, Rydén, Anna, Fagerberg-Mohlin, Bodil, Finizia, Caterina

“…Summary Objectives To develop and validate a comprehensive, self-administered questionnaire for patients with limited ability to open the mouth, trismus…”
Get full text

Self‐compassion in mindfulness‐based stress reduction: An examination of prediction and mediation of intervention effects by Sevel, Landrew S., Finn, Micheal T.M., Smith, Rachel M., Ryden, Anna M., McKernan, Lindsey C.

“…The current investigation sought to clarify mechanisms of treatment effects in mindfulness‐based stress reduction (MBSR). Self‐compassion and mindful awareness…”
Get full text

Self evaluation of communication experiences after laryngeal cancer - a longitudinal questionnaire study in patients with laryngeal cancer by Johansson, Mia, Rydén, Anna, Finizia, Caterina

“…Aim of this longitudinal study was to investigate the sensitivity to change of the Swedish Self Evaluation of Communication Experiences after Laryngeal Cancer…”
Get full text

Discrete Choice Experiment Attribute Selection Using a Multinational Interview Study: Treatment Features Important to Patients with Type 2 Diabetes Mellitus by Rydén, Anna, Chen, Stephanie, Flood, Emuella, Romero, Beverly, Grandy, Susan

“…Introduction Methods for discrete choice experiment (DCE) attribute and attribute-level selection have not yet been firmly established and are rarely reported…”
Get full text

GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients by Hjorth, Maria, Axelsson, Stina, Rydén, Anna, Faresjö, Maria, Ludvigsson, Johnny, Casas, Rosaura

“…Type 1 diabetes results from autoimmune destruction of insulin producing pancreatic β-cells. We have shown that treatment with alum-formulated glutamic acid…”
Get full text

Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors by Rydén, Anna, Denison, Hans, Karlsson, Maria, Vakil, Nimish

“…Abstract Objective. The Reflux Symptom Questionnaire 7-day recall (RESQ-7) was developed, in line with the US Food and Drug Administration (FDA) guidelines, to…”
Get full text